Search

everythinglearnresearchcommunity

for

Search:↓

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Hurricane Sandy increased contamination in estuarine sediments in New Jersey and New York.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Dermatologists play a key role in identifying and documenting signs of abuse and injury for forensic investigations.

Bioluminescence imaging can track hair follicle cells and help study hair regrowth.

Alternative treatments show promise for hair growth beyond traditional methods.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.

The document concludes that scalp health is influenced by complex factors affecting sebaceous glands, including hormones, aging, and various substances.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.